Group ACYW135 Meningococcal Polysaccharide Vaccine (Changchun Changsheng Life Sciences)

ACYW135็พค่„‘่†œ็‚Ž็ƒ่Œๅคš็ณ–็–ซ่‹—๏ผˆ้•ฟๆ˜ฅ้•ฟ็”Ÿ็”Ÿ็‰ฉ็ง‘ๆŠ€๏ผ‰

Report date: 2025/08/01 16:03:00

Base Information

Drug NameGroup ACYW135 Meningococcal Polysaccharide Vaccine (Changchun Changsheng Life Sciences)
Drug Alias NameGroup A, C, Y, W135-meningococcal polysaccharide vaccine (Changchun Changsheng Life Sciences)Aใ€Cใ€Yใ€W135-็พค่„‘่†œ็‚Ž็ƒ่Œๅคš็ณ–็–ซ่‹—๏ผˆ้•ฟๆ˜ฅ้•ฟ็”Ÿ็”Ÿ็‰ฉ็ง‘ๆŠ€๏ผ‰
ClassificationVaccines > Biological material > Bacterial vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsEncephalomyelitis
Global Approved IndicationsEncephalomyelitis
Approved Indications in ChinaEncephalomyelitis
Original Approved Country/TerritoryMainland China
Original Approved Date2013/10/24
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaWithdrawn
Originator CompaniesChangchun Longevity Biological Technology Limited Liability Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChangchun Changsheng Gene Pharmaceutical Stock Co Ltd
Active IndicationsN/A
Inactive IndicationsEncephalomyelitis

Other Information

ATC CodeJ07AH04
Related LinksN/A